TrialJournal of primary care & community health

Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.

Andrew M Blumenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.